Genomics

Dataset Information

0

Oncogenic ZEB2 activation drives sensitivity towards LSD1 inhibition in T-cell acute lymphoblastic leukemia

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE83128 | GEO | 2017/02/03

SECONDARY ACCESSION(S): PRJNA324824

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.
| S-EPMC5783288 | biostudies-literature
Genomics Oncogenic ZEB2 activation drives sensitivity towards LSD1 inhibition in T-cell acute lymphoblastic leukemia
| PRJNA324824 | ENA
Unknown Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia.
| S-EPMC6726528 | biostudies-literature
Unknown Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia.
| S-EPMC3556576 | biostudies-literature
Unknown SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.
| S-EPMC3538327 | biostudies-literature
Unknown Leukemia Cell of Origin Influences Apoptotic Priming and Sensitivity to LSD1 Inhibition.
| S-EPMC7584353 | biostudies-literature
Unknown MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
| S-EPMC5885022 | biostudies-literature
Unknown MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
| S-EPMC3960194 | biostudies-other
Unknown Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
| S-EPMC4246039 | biostudies-literature
Unknown JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.
| S-EPMC6028512 | biostudies-literature